Inventor
THOMAS-TRAN RHIANNON
US15 patents
⚠️ This page may combine multiple inventors who share the name “THOMAS-TRAN RHIANNON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GILEAD SCIENCES INC
9 patentsUS11858918B2Jan 2, 2024
GLP-1R modulating compounds
GILEAD SCIENCES INC7 citations84
US11702404B2Jul 18, 2023
GLP-1R modulating compounds
GILEAD SCIENCES INC9 citations84
US12091404B2Sep 17, 2024
GLP-1R modulating compounds
GILEAD SCIENCES INC3 citations74
US12121511B2Oct 22, 2024
GLP-1R modulating compounds
GILEAD SCIENCES INC3 citations73
US11897862B2Feb 13, 2024
IKAROS zinc finger family degraders and uses thereof
GILEAD SCIENCES INC2 citations70
US12570642B2Mar 10, 2026
GLP-IR modulating compounds
GILEAD SCIENCES INC0 citations61
US12497382B2Dec 16, 2025
GLP-1R modulating compounds
GILEAD SCIENCES INC0 citations61
US12358887B2Jul 15, 2025
IKAROS Zinc Finger Family degraders and uses thereof
GILEAD SCIENCES INC0 citations59
US12122764B2Oct 22, 2024
IKAROS zinc finger family degraders and uses thereof
GILEAD SCIENCES INC0 citations50
ARCUS BIOSCIENCES INC
6 patentsUS10399962B2Sep 3, 2019
Azolopyrimidine for the treatment of cancer-related disorders
ARCUS BIOSCIENCES INC13 citations80
US11072597B2Jul 27, 2021
Azolopyrimidine for the treatment of cancer-related disorders
ARCUS BIOSCIENCES INC3 citations69
US11045472B2Jun 29, 2021
Quinazoline-pyridine derivatives for the treatment of cancer-related disorders
ARCUS BIOSCIENCES INC1 citations61
US12195447B2Jan 14, 2025
Azolopyrimidine for the treatment of cancer-related disorders
ARCUS BIOSCIENCES INC1 citations60
US12410170B2Sep 9, 2025
2,3,5-trisubstituted pyrazolo[1,5-A]pyrimidine compounds
ARCUS BIOSCIENCES INC0 citations48
US11931343B2Mar 19, 2024
CD73 inhibitors
ARCUS BIOSCIENCES INC0 citations48